PCI Pharmaceutical Consulting

Similar documents
cgmp Update Presented by: Karen Ginsbury For IFF, Denmark November 2016

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

GxP Auditing, Remediation, and Staff Augmentation

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Quality Assessment & GMP Similarities & Differences

Regulatory Update. Paul Sexton. QP Forum

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

EU and FDA GMP Regulations: Overview and Comparison

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics

A Comprehensive Approach to Find and Remediate Data Integrity Problems

Self-Inspection and its potential benefits via ICH Q9 & Q10

GxP Auditing, Remediation, and Staff Augmentation

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management

Contents. Contents (13) 1 Production (23)

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Testo Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance

FDA Quality Metrics Guidance

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW

Quality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR

Overview of Regulatory Requirements for API and Formulations

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

Quality Metrics: A Regulatory Perspective

Overview sulla nuova guideline GDP

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Quality Risk Management: Excipients

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Risk Analysis: myths, confusions and real sense

FDA s Draft Guidance Request for Quality Metrics: What All Drug and Biologics Manufacturers Need to Know June 2017

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

GxP Auditing, Remediation, and Quality System Resourcing

Outsourcing - managing risks and opportunities over which you now have less control

Q10 PHARMACEUTICAL QUALITY SYSTEM

Conducting Supplier Audits: Ensure Validation Compliance

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00

Management System Hilton Olympia, London 13 th February 2013

GMP Track 1 Day 2 Session 1 Vendor Assurance

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Developing an Internal Quality Auditing Program

Managing Quality in Pharmaceutical Industry Using Six Sigma. Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018

Guidance for Industry

Materials Management Traceability, CEPs and managing non-conforming sites

CV Mads Friis Sørensen, Elsdyrvej 18, 4623 Lille Skensved

Metrics in Microbiology Monitoring Practices

Journal home page: RESEARCH ARTICLE

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

White paper Audits in automated production

Handling OOS, OOT and Unexpected Results. Karen Ginsbury PCI Pharmaceutical Consulting Israel Ltd for IFF, October 2017

EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016

Prequalification of Medicines Programme

Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer

Quality Management (PQM01) Chapter 04 - Quality Control

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)

Data Integrity: Points of view from a regulator

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines

T H E P R O P O S A L F O R T H E Y E A R

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013.

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Excipient GMP GDP Certification Project. Presentation to FECC Seminar Brussels 19 th March 2009 Dr Iain Moore Chair GMP Committee IPEC Europe

Scientific & Risk Based Compliance

Regulatory Compliance Inspections at MAH Offices: Implications for Manufacturers

Supplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015

GMP for ATMP should be a document annexed to standard GMP (a new Annex) and not a stand-alone document.

Online Student Guide Types of Control Charts

Supplier Assurance Program. CBE Pty Ltd

CBER Expectations Regarding Contract Manufacturing

MHRA S NORMAN GRAY ON ANNEX 15 REVISION AND VALIDATION INSPECTION FINDINGS

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

MASTER PLANNING FOR VALIDATION

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.

Comments from: 1. General comments. International Plasma Fractionation Association (IPFA) Our ref. IP

BATCH DISPOSITION BATCH DISPOSITION REGULATION. Jakarta 14 DECEMBER Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT

Strategies to Revise Quality Policy and Quality Objectives. Eileen Cortes February 22, 2017

Culture & the QP. Frank Hallinan Annual QP Forum 16 April 2015.

Transcription:

PCI Pharmaceutical Consulting The Role of the QP: before & after Annex 16 Presented by: Karen Ginsbury For IFF, Denmark March 2016

Responsibility Authority

Responsibility Authority Having the duty to perform a task Being accountable for performing that task Having control over the performance of the task Without additional authorization The power or right to give orders, make decisions, and enforce obedience Within the framework of a company or organization

Responsibility YOUR duty to: Keep management informed Request and insist on appropriate resources Take action if authority is not granted Authority must be granted by: Owner Board of directors General manager / CEO Your boss if other than the above AND they must allow you to perform your responsibilities without interference and with appropriate resources

Responsibility vs Authority

The behaviors, beliefs and values characteristic of a particular group Culture is: Transmitted actively by defining: Mission Goals Metrics Transmitted passively and often subconsciously by behavior, body language, facial expressions and other actions

Better do it now Quality Quality System

What sort of Organization do you work in / with? active and visible support

Grumpy Cat What has changed? What is your most challenging issue?

What s Troubling Me

Certification by a QP and Batch Release: Annex 16 Issued October 2015 Effective 15 APRIL, 2016 Reason for update: SUPPLY CHAIN

Certification by a QP and Batch Release: Annex 16 Reason for update: SUPPLY CHAIN and FALSIFIED MEDICINES ACT, ICH Q8, 9, 10

Let s look at Annex 16 What jumps out?

Annex 16 Batch release pre-requisites Supplier qualification and falsified medicines directive API and excipients: Audits quality agreements CMOs: Production Packaging Other service providers

Annex 16 Batch release pre-requisites Validation and qualification (annex 15) in or out of scope? Computerized systems (annex 11) especially for batch release and inventory in or out of scope? Batch record review and data integrity

Annex 16 Batch release pre-requisites QP discretion CAPA, investigations And before any of that process mapping and risk assessment!

Risk Assessment for Excipients

What s Troubling the Inspector 2015 #1 Data integrity #2 Quality Culture (???) (attitude of most senior management??) leadership? #3 Quality Metrics #4 Drug Shortages #5 Supply chain and falsified medicines (although ties in with #1 closely)

GMP / GDP Inspectors Working Group

FDA Guidance Agenda 2015

What changes in last 12 months EU GMPs Part 1 Cap 3: Premises and Equipt Cap 5: Production Cap 8: Complaints, Recalls Effective: 01 Mar 2015 01 Mar 2015 01 Mar 2015 Annex 1 Annex 15 Annex 16 Annex 17 Concept paper on revision 01 Oct 2015 01 April 2016 Draft out

3 Premises and Equipment 3.6 as part of improved guidance on prevention of cross-contamination involving Cap 5

5 - Production

8 Complaints, Quality Defects and Product Recalls

Annex 15 Validation

Annex 17: Real Time Release Testing RTRT 26

Other US GMPs: 21CFR parts 210, 211, part 11 and part 820 FDA guidances: Draft guidance on quality metrics Quality system guidance vs ICH Q8, 9, 10 Process validation guidance Contract Manufacture

Other MHRA Compliance Report program and FDA on quality metrics WHO Guidances PIC/s Guidances USP, European Pharmacopoeia Pulling together the threads and staying updated

Hot Topics Data Integrity

Data Integrity does your company have a data governance policy?

What is Quality Meeting requirements all of them all the time and that means defining the requirements Annex 16 defines requirements for batch certification and release

Waivers the act of intentionally [and voluntarily] relinquishing or abandoning a known right, claim, or privilege So a planned deviation or temporary change or special release is a waiver of quality which is meeting requirements (all of them all the time)

Have you Heard About ISO 9001:2015?

Product control What is the difference Process control

Product vs Process Control Product Is controlled at the end of the process and you can do nothing about it you have already made the quality so you test and if it is ok release and if it is not ok you SHOULD reject but you probably get into an OOS fight Process Is controlled through understanding where the variability is and controlling critical process parameters such that all three cakes come out the same even when baked by three different students in three different ovens

My bread is fresh and tasty Quality control: the process of producing the product (or service) with the intent of eliminating problems that might result in defects The use of techniques and activities to achieve, sustain and improve the quality of a product

Where does QP Responsibility Fit? Certification and Release 37

CPPs and CQAs (Critical) Quality Attribute (CQA): A physical, chemical, biological or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product quality [= safety, efficacy, performance] (Critical) Process Parameter (CPP): A process parameter whose variability has an impact on a critical quality attribute and therefore should be monitored or controlled to ensure the process produces the desired quality 38

115 110 105 100 95 90 115 110 105 100 95 90 85 80 115 110 105 100 95 90 85 80 120 115 110 105 100 95 90 115 110 105 100 95 90 110 105 100 95 90 85 60 40 40 20 60 80 62 42 42 22 62 82 64 44 44 24 64 84 66 46 46 26 66 86 I Chart 68 70 72 Observation I Chart 48 50 52 Observation I Chart 48 50 52 Observation I Chart 28 30 32 Observation I Chart 68 70 72 Observation I Chart 88 90 92 Observation 74 54 54 34 74 94 76 56 56 36 76 96 78 58 58 38 78 98 80 60 60 40 80 100 UCL=111.55 _ X=99.63 LCL=87.71 UCL=112.65 _ X=97.94 LCL=83.23 UCL=112.65 _ X=97.94 LCL=83.23 UCL=116.68 _ X=102.37 LCL=88.05 UCL=111.55 _ X=99.63 LCL=87.71 UCL=111.17 _ X=98.76 LCL=86.35 CPPs affect CQAs: Reliable / Predictable Known variation / Reduce Variation I N P U T S (X) Individual Value People Equipment Individual Value Measurement Individual Value Individual Value Process y = ƒ(x) Inputs to the process control variability of the Output y Individual Value OUTPUT Materials Individual Value Individual Value 115 110 105 100 95 90 85 1 11 21 31 I Chart 41 51 61 Observation 71 81 91 UCL=114.17 _ X=99.95 LCL=85.72 Environment Adapted from slide by Moheb Naser, When at FDA 39 39

George Bernard Shaw The only man I know who behaves sensibly is my tailor - he takes my measurements anew each time he sees me. The rest go on with their old measurements and expect me to fit them

FDA Metrics

FDA Optional Metrics Related to Quality Culture and Process Capability/Performance

Optional metric #2

Optional metric #2

Optional metric #3

What Quality Data Would Be Reported

What Quality Data Would Be Reported

Measurement is the basis of the Quality Process What do we measure What could we measure What should we measure What can we measure

Data Collection Plans (Protocols) What data NEEDS to be collected (if all data is important then none is important) HOW should it be collected? HOW should it be analyzed? HOW should it be presented? And by who and to whom? 49

How many metrics BE CAREFUL if everything is important then nothing is important

About Measurement Measurement is the first step that leads to control and eventually to improvement If you can t measure something, you can t understand it If you can t understand it, you can t control it If you can t control it, you can t improve it. H. James Harrington

Measureable But Meaningful If a measurement matters at all, it is because it must have some conceivable effect on decisions and behavior If we can't identify a decision that could be affected by a proposed measurement and how it could change those decisions, then the measurement simply has no value Douglas W. Hubbard, How to Measure Anything: Finding the Value of Intangibles in Business

Data Collection Plans Who decides what data to collect? How do they make that decision? How do they COMMUNICATE the decision? (what are the tools) How do they educate for compliance with the data collection plan?

The toolbox Fabulous 14 Tools Process flow diagram Cause and effect (fishbone) Pareto chart Check sheets Location diagrams Tally count Time plot Scatter diagram Histogram Stem and Leaf Box and Whisper plot Regression analysis Control Chart Conformance chart

Dashboards Dashboards are reporting tools that consolidate and arrange numbers, metrics and sometimes scorecards on a single screen Usually tailored for a specific role Display metrics targeted for a single point of view or department

Dashboards

The Power of Walking the Floor Thoughts?

The Power of Walking the Floor You see but you do not observe Just stand and watch a production operation and ask questions about what you see Talk to operators and LISTEN to their comments You must understand the processes you are certifying

In Conclusion GMP isn t enough even if c Keep it Simple: Define requirements Use Risk Management to identify risks and prevent them from happening Monitor and improve in a PDCA cycle

In Conclusion Stay up to date Stay cool, calm and collected Ask for and make sure you get data and information in order to make informed decisions Have process maps and regularly audit or have links in the chain audited by people you trust Investigate and participate in significant deviations, changes and quality defects / complaints Refuse to be brushed aside with an it s ok Use RISK MANAGEMENT not just take risks

FIND ME AT: karen@pcipharma.com THANK YOU FOR PARTICIPATING